西布曲明
酚酞
减肥
氟西汀
传统医学
医学
膳食补充剂
草药补充剂
化学
药理学
食品科学
肥胖
替代医学
内科学
有机化学
受体
血清素
病理
作者
Ammar Abdulrahman Jairoun,Sabaa Saleh Al‐Hemyari,Moyad Shahwan,Sa’ed H. Zyoud
出处
期刊:Molecules
[MDPI AG]
日期:2021-11-16
卷期号:26 (22): 6903-6903
被引量:23
标识
DOI:10.3390/molecules26226903
摘要
Weight loss supplements that have illegal additives of pharmaceutical drugs or analogues have additional health risks, and customers may not be aware of what they are taking. This research is an essential investigation and quantification of illegally added pharmaceuticals or prescription medications, specifically fluoxetine, phenolphthalein, and sibutramine, in herbal weight loss supplements offered for sale in the United Arab Emirates (UAE). In this case, 137 weight loss supplements were collected and analyzed in this study. Reversed-phase high-performance liquid chromatography with UV absorption detection coupled to tandem mass spectrometry (RP-HPLC-MS/MS) analyses were used to determine the presence of the pharmaceutical chemicals. Among the weight loss supplements, 15.3% (95% CI: 9.2-21.4) contained undeclared sibutramine, 13.9% (95% CI: 8.01-19.7) contained undeclared phenolphthalein, and 5.1% (95% CI: 1.4-8.8) contained undeclared fluoxetine. Amongst all weight loss supplements, 17.5% (95% CI: 11.07-24) contained significant concentrations of either sibutramine, phenolphthalein, or fluoxetine. Whilst weight loss herbal supplements offered for sale in the UAE have relatively low percentages of undeclared pharmaceuticals, many people take several different supplements daily and may encounter quite high levels of combined exposure to toxic compounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI